Pei Li Nong Ben Fang: 2022 interim report
Purapharm Swings to H1 Loss on Lower Sales
09:38 PM EDT, 08/28/2022 (MT Newswires) -- Purapharm (HKG:1498) swung to a loss in the first half, weighed down by a drop in revenue, according to a Sunday bourse disclosure. Attributable loss at the
Peili Nong Ben Fang: interim results announcement for the six months ended June 30, 2022
Peili agricultural side: profit warning
Pei Li Nong Ben Fang: 2021 Annual report
Purapharm Turns to Loss in 2021 on Impairment Loss of Goodwill; Shares Fall 4%
02:30 AM EDT, 03/30/2022 (MT Newswires) -- Purapharm (HKG:1498) swung to a loss of HK$0.3095 ($0.040) per diluted share in 2021 from earnings of HK$8.54 a year prior. Loss attributable to owners of th
Pei Li Nong Ben Fang: annual results announcement and proposed amendments to articles of association for the year ended December 31, 2021
Pei Li Nong Ben Fang: notice of board meeting
Purapharm Forecasts Turn to Loss in 2021
04:18 AM EST, 02/28/2022 (MT Newswires) -- Purapharm (HKG:1498) expects to swing to a net loss of up to HK$140 million ($17.9 million) in 2021 from a net profit of HK$31.7 million a year prior, accord
The concept stock of traditional Chinese medicine rose strongly. Pei Li Nong Ben Fang (01498) rose 5.62%.
Phoenix New Media Hong Kong stock | traditional Chinese medicine concept stock rose strongly. Peili Nong Ben Fang (01498) rose 5.62%, Chinese traditional medicine (00570) rose 5.38%, Tongrentang Technology (01666) rose 2.96%, Modern traditional Chinese Medicine Group (01643) rose 2.47%. Shenwei Pharmaceutical (02877) rose 1.46%. On the face of the news, the State Drug Administration held a forum to promote the comprehensive revitalization of the Northeast. The meeting stressed the need to do a good job in the drug regulatory system to support the comprehensive revitalization of the Northeast. It is necessary to deepen the reform of the examination and approval system, smooth communication channels, speed up the listing of innovative products, and encourage pharmaceutical enterprises.